Rafi Syed

Linus Biotechnology, Inc. is an American company that specializes in the discovery of novel biomarkers for diagnostics, objective endpoints in clinical trials, measurements of therapeutic effect of investigational compounds, and outcome measurements. The company is based in Seattle, WA and was founded in 2020 by Paul Curtin, Christine Austin, and Manish Arora. The company's platform encompasses proprietary laser and robotics hardware, data science, and a unique data set connecting the human exposome to clinical outcomes. Manish Arora has been the CEO since 2020.

Linus Biotechnology, Inc. is an American company that specializes in the discovery of novel biomarkers for diagnostics, objective endpoints in clinical trials, measurements of therapeutic effect of investigational compounds, and outcome measurements. The company is based in Seattle, WA and was founded in 2020 by Paul Curtin, Christine Austin, and Manish Arora. The company's platform encompasses proprietary laser and robotics hardware, data science, and a unique data set connecting the human exposome to clinical outcomes. Manish Arora has been the CEO since 2020.

Linus Biotechnology, Inc. is an American company that specializes in the discovery of novel biomarkers for diagnostics, objective endpoints in clinical trials, measurements of therapeutic effect of investigational compounds, and outcome measurements. The company is based in Seattle, WA and was founded in 2020 by Paul Curtin, Christine Austin, and Manish Arora. The company's platform encompasses proprietary laser and robotics hardware, data science, and a unique data set connecting the human exposome to clinical outcomes. Manish Arora has been the CEO since 2020.

Linus Biotechnology, Inc. is an American company that specializes in the discovery of novel biomarkers for diagnostics, objective endpoints in clinical trials, measurements of therapeutic effect of investigational compounds, and outcome measurements. The company is based in Seattle, WA and was founded in 2020 by Paul Curtin, Christine Austin, and Manish Arora. The company's platform encompasses proprietary laser and robotics hardware, data science, and a unique data set connecting the human exposome to clinical outcomes. Manish Arora has been the CEO since 2020.

Linus Biotechnology, Inc. is an American company that specializes in the discovery of novel biomarkers for diagnostics, objective endpoints in clinical trials, measurements of therapeutic effect of investigational compounds, and outcome measurements. The company is based in Seattle, WA and was founded in 2020 by Paul Curtin, Christine Austin, and Manish Arora. The company's platform encompasses proprietary laser and robotics hardware, data science, and a unique data set connecting the human exposome to clinical outcomes. Manish Arora has been the CEO since 2020.